Compare IQV & TRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IQV | TRI |
|---|---|---|
| Founded | 1982 | 1851 |
| Country | United States | Canada |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3B | 37.0B |
| IPO Year | 2013 | 2002 |
| Metric | IQV | TRI |
|---|---|---|
| Price | $166.19 | $83.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 11 |
| Target Price | ★ $233.33 | $164.55 |
| AVG Volume (30 Days) | 2.6M | ★ 2.9M |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.87% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 7.84 | N/A |
| Revenue | ★ $9,739,000,000.00 | N/A |
| Revenue This Year | $6.77 | $8.86 |
| Revenue Next Year | $5.91 | $7.86 |
| P/E Ratio | ★ $21.59 | $25.72 |
| Revenue Growth | ★ 41.60 | N/A |
| 52 Week Low | $134.65 | $81.91 |
| 52 Week High | $247.05 | $218.40 |
| Indicator | IQV | TRI |
|---|---|---|
| Relative Strength Index (RSI) | 26.66 | 23.15 |
| Support Level | $161.94 | $81.91 |
| Resistance Level | $171.14 | $86.53 |
| Average True Range (ATR) | 10.96 | 5.53 |
| MACD | -2.88 | -0.13 |
| Stochastic Oscillator | 15.47 | 11.54 |
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.